Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis (Q40512234)

21 September 2017

Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis (English)

1 reference

fibrin degradation product

21 September 2017

0 references

1 reference

Weitz JI

1

1 reference

21 September 2017

Leslie B

series ordinal

2

1 reference

21 September 2017

Ginsberg J

series ordinal

3

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 March 1991

1 reference

Journal of Clinical Investigation

21 September 2017

1 reference

21 September 2017

87

1 reference

21 September 2017

3

1 reference

21 September 2017

1082-1090

1 reference

Protein measurement with the Folin phenol reagent

21 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=329904

DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=329904

Labelling of plasma proteins with radioactive iodine

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=329904

Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=329904

Plasmic degradation of crosslinked fibrin. Characterization of new macromolecular soluble complexes and a model of their structure

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=329904

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=329904

Structural and kinetic comparison of recombinant human single- and two-chain tissue plasminogen activator

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=329904

Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=329904

Quantitation of fragment X formation during thrombolytic therapy with streptokinase and tissue plasminogen activator

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=329904

Binding phenomena of isolated unique plasmic degradation products of human cross-linked fibrin

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=329904

Primary soluble plasmic degradation product of human crosslinked fibrin. Isolation and stoichiometry of the (DD)E complex

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=329904

Molecular mechanism of physiological fibrinolysis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=329904

On the biological significance of the specific interaction between fibrin, plasminogen and antiplasmin

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=329904

Comparative properties of two clinical preparations of recombinant human tissue-type plasminogen activator in patients with acute myocardial infarction

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=329904

[Identification of a (D-D)...E complex in degradation products of bovine fibrin stabilized by factor XIII]

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=329904

Subunit structure of fragment D from fibrinogen and cross-linked fibrin.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=329904

A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=329904

Plasminogen activation by tissue activator is accelerated in the presence of fibrin(ogen) cyanogen bromide fragment FCB-2.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=329904

Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=329904

Studies on the kinetics of plasminogen activation by tissue plasminogen activator

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=329904

Fibrinogen lysine residue A alpha 157 plays a crucial role in the fibrin-induced acceleration of plasminogen activation, catalyzed by tissue-type plasminogen activator

20 August 2018

1 reference

12 December 2020

A kinetic analysis of fibrinogenolysis during plasminogen activator therapy

1 reference

12 December 2020

Acute pulmonary embolism treated with tissue plasminogen activator

1 reference

12 December 2020

Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism

1 reference

12 December 2020

Coronary thrombolysis with recombinant tissue-type plasminogen activator. A hematologic and pharmacologic study

1 reference

12 December 2020

Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen Activator

1 reference

12 December 2020

Development of a radioimmunoassay for the fibrinogen-derived peptide B beta 1-42

1 reference

12 December 2020

Identification of a site in fibrin(ogen) which is involved in the acceleration of plasminogen activation by tissue-type plasminogen activator

1 reference

12 December 2020

The binding of human plasminogen to fibrin and fibrinogen

1 reference

12 December 2020

Subunit structure of the plasmin-induced degradation products of crosslinked fibrin

1 reference

12 December 2020

C-terminal lysine residues of fibrinogen fragments essential for binding to plasminogen

1 reference

12 December 2020

Characterisation of epitopes on human tissue plasminogen activator recognised by a group of monoclonal antibodies

1 reference

12 December 2020

Fibrinolytic properties of one-chain and two-chain human extrinsic (tissue-type) plasminogen activator

1 reference

12 December 2020

Activation of plasminogen by tissue activator is increased specifically in the presence of certain soluble fibrin(ogen) fragments

1 reference

12 December 2020

Differences in effects of fibrin(ogen) fragments on the activation of 1-glu-plasminogen and 442-VAL-plasminogen by tissue-type plasminogen activator

1 reference

12 December 2020

Location of plasminogen-binding sites in human fibrin(ogen)

1 reference

12 December 2020

Plasmic degradation of crosslinked fibrin. I. Structural analysis of the particulate clot and identification of new macromolecular-soluble complexes

1 reference

12 December 2020

Structure of fragment E species from human cross-linked fibrin

1 reference

12 December 2020

Binding of plasmin(ogen) to sepharose bound fibrin(ogen) alpha-chain

1 reference

12 December 2020

Coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarction

1 reference

12 December 2020

Thrombolysis, clot selectivity, and kinetics

1 reference

12 December 2020

Beta(Leu121-Lys122) segment of fibrinogen is in a region essential for plasminogen binding by fibrin fragment E

1 reference

12 December 2020

Importance of intramolecular interactions in the control of the fibrin affinity and activation of human plasminogen

1 reference

12 December 2020

Identifiers

DOI

10.1172/JCI115069

1 reference

21 September 2017

1 reference

21 September 2017

1 reference